ArticleNature medicine2026

Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial.

Pablo García-Pavía et al.PubMed ↗Publisher ↗

No numbers read from the abstract.